Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric canceropen access

Authors
Kim, HyeongiZaheer, JaveriaChoi, Eui-JuKim, Jin Su
Issue Date
2022
Publisher
IVYSPRING INT PUBL
Keywords
Microplastics; gastric cancer; cancer hallmarks; polystyrene; ASGR2
Citation
THERANOSTICS, v.12, no.7, pp.3217 - 3236
Indexed
SCIE
SCOPUS
Journal Title
THERANOSTICS
Volume
12
Number
7
Start Page
3217
End Page
3236
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/142150
DOI
10.7150/thno.73226
ISSN
1838-7640
Abstract
Background: Microplastics (MPs) are a new global environmental threat. Previously, we showed the biodistribution of MPs using [Cu-64] polystyrene (PS) and PET in mice. Here, we aimed to identify whether PS exposure has malignant effects on the stomach and induces resistance to therapy. Methods: BALB/c nude mice were fed 1.72 x 10(4) particles/mL of MP. We investigated PS accumulation in the stomach using radioisotope-labeled and fluorescent-conjugated PS. Further, we evaluated whether PS exposure induced cancer stemness and multidrug resistance, and whether it affected tumor development, tumor growth, and survival rate in vivo using a 4-week PS-exposed NCI-N87 mouse model. Using RNA-Seq analysis, we analyzed whether PS exposure induced gene expression changes in gastric tissues of mice. Results: PET imaging results showed that a single dose of [Cu-64]-PS remained for 24 h in the mice stomach. The 4-week daily repetitive dose of fluorescent conjugated PS was deposited in the gastric tissues of mice. When PS was exposed, a 2.9-fold increase in migration rate was observed for NCI-N87 cells. Immunocytochemistry results showed decreased E-cadherin and increased N-cadherin expression, and flow cytometry, qPCR, and western blot analysis indicated a 1.9-fold increase in N-cadherin expression after PS exposure. Further, PS-induced multidrug resistance to bortezomib, paclitaxel, gefitinib, lapatinib, and trastuzumab was observed in the NCI-N87 mouse model due to upregulated CD44 expression. RNA-seq results identified increased asialoglycoprotein receptor 2 (ASGR2) expression after PS exposure, and ASGR2 knockdown decreased cell proliferation, migration, invasion, and drug resistance. Conclusion: We demonstrated that ASGR2 enhanced cancer hallmarks on PS exposure and induced resistance to chemo- and monoclonal antibody-therapy. Our preclinical findings may provide an incentive for further epidemiological studies on the role of MP exposure and its association with gastric cancer.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Life Sciences and Biotechnology > Division of Life Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE